Literature DB >> 36261231

Association between socioeconomic status and mucosal healing in Japanese patients with ulcerative colitis: a cross-sectional study.

Shogo Kitahata1, Shinya Furukawa2, Teruki Miyake3, Kana Shiraishi3, Kazuhiro Tange4, Yu Hashimoto3, Sen Yagi5, Tomoyuki Ninomiya1, Seiyuu Suzuki6, Naozumi Shibata7, Hidehiro Murakami8, Katsuhisa Ohashi9, Hideomi Tomida10, Yasunori Yamamoto10, Eiji Takeshita4, Yoshio Ikeda10, Yoichi Hiasa3.   

Abstract

OBJECTIVE: Socioeconomic status is a risk factor for worse outcomes in many diseases. However, evidence on the association between socioeconomic status and clinical outcome in patients with ulcerative colitis (UC) is limited. In the clinical setting, the therapeutic goal for UC is to achieve mucosal healing (MH). Thus, the aim of this study is to examine the association between socioeconomic status and MH in patients with UC.
METHODS: The study population consisted of 298 patients with UC. Education status and household income were divided into three groups based on a self-administered questionnaire. MH and complete MH were defined as a Mayo endoscopic subscore of 0-1 and 0, respectively. The association of socioeconomic status with MH and complete MH was assessed by multivariate logistic regression analysis. Patients with UC were divided into a younger group (<51 years old) and an older group (≥51 years old) based on median age.
RESULTS: The percentage of MH and complete MH was 62.4% and 25.2%, respectively. In all patients, socioeconomic status was not associated with MH and complete MH, respectively. In the older group, education but not household income was independently positively associated with MH and complete MH. In contrast, in the younger group, no association between socioeconomic status and MH and complete MH was found.
CONCLUSION: In older Japanese patients with UC, education status but not household income was independently positively associated with MH and complete MH. © Author(s) (or their employer(s)) 2022. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.

Entities:  

Keywords:  EPIDEMIOLOGY; INFLAMMATORY BOWEL DISEASE; ULCERATIVE COLITIS

Mesh：

Year:  2022        PMID： 36261231      PMCID： PMC9582296          DOI： 10.1136/bmjgast-2022-001000

Source DB:  PubMed          Journal:  BMJ Open Gastroenterol        ISSN： 2054-4774


  26 in total

1.  Nationwide linkage analysis in Scotland to assess mortality following hospital admission for Crohn's disease: 1998-2000.

Authors:  N A Kennedy; D N Clark; J Bauer; A M Crowe; A D Knight; R J Nicholls; J Satsangi
Journal:  Aliment Pharmacol Ther       Date:  2011-11-09       Impact factor: 8.171

2.  Literature review: impacts of socioeconomic status on the risk of inflammatory bowel disease and its outcomes.

Authors:  Richard A Wardle; Andrew J Wardle; Creana Charadva; Subrata Ghosh; Gordon W Moran
Journal:  Eur J Gastroenterol Hepatol       Date:  2017-08       Impact factor: 2.566

3.  Socioeconomic and psychological factors associated with nonadherence to treatment in inflammatory bowel disease patients: results of the ISSEO survey.

Authors:  Stéphane Nahon; Pierre Lahmek; Catherine Saas; Christelle Durance; Alain Olympie; Bruno Lesgourgues; Jean-Pierre Gendre
Journal:  Inflamm Bowel Dis       Date:  2010-10-25       Impact factor: 5.325

4.  Nationwide linkage analysis in Scotland-Has mortality following hospital admission for Crohn's disease changed in the early 21st century?

Authors:  Nicholas T Ventham; Nick A Kennedy; Andrew Duffy; David N Clark; Alison M Crowe; Alastair D Knight; R John Nicholls; Jack Satsangi
Journal:  J Crohns Colitis       Date:  2014-09-26       Impact factor: 9.071

5.  Factors associated with thiopurine non-adherence in patients with inflammatory bowel disease.

Authors:  J R Goodhand; N Kamperidis; B Sirwan; L Macken; N Tshuma; Y Koodun; F A Chowdhury; N M Croft; N Direkze; L Langmead; P M Irving; D S Rampton; J O Lindsay
Journal:  Aliment Pharmacol Ther       Date:  2013-09-15       Impact factor: 8.171

6.  Social Determinants of Outcomes in Inflammatory Bowel Disease.

Authors:  Charles N Bernstein; Randy Walld; Ruth Ann Marrie
Journal:  Am J Gastroenterol       Date:  2020-12       Impact factor: 10.864

Review 7.  Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE): Determining Therapeutic Goals for Treat-to-Target.

Authors:  L Peyrin-Biroulet; W Sandborn; B E Sands; W Reinisch; W Bemelman; R V Bryant; G D'Haens; I Dotan; M Dubinsky; B Feagan; G Fiorino; R Gearry; S Krishnareddy; P L Lakatos; E V Loftus; P Marteau; P Munkholm; T B Murdoch; I Ordás; R Panaccione; R H Riddell; J Ruel; D T Rubin; M Samaan; C A Siegel; M S Silverberg; J Stoker; S Schreiber; S Travis; G Van Assche; S Danese; J Panes; G Bouguen; S O'Donnell; B Pariente; S Winer; S Hanauer; J-F Colombel
Journal:  Am J Gastroenterol       Date:  2015-08-25       Impact factor: 10.864

8.  Socioeconomic Status and Race are both Independently associated with Increased Hospitalization Rate among Crohn's Disease Patients.

Authors:  Caroline Walker; Chaitanya Allamneni; Jordan Orr; Huifeng Yun; Paul Fitzmorris; Fenglong Xie; Talha A Malik
Journal:  Sci Rep       Date:  2018-03-05       Impact factor: 4.379

9.  Trends in corticosteroid prescriptions for ulcerative colitis and factors associated with long-term corticosteroid use: analysis using Japanese claims data from 2006 to 2016.

Authors:  Katsuyoshi Matsuoka; Ataru Igarashi; Noriko Sato; Yuri Isono; Maki Gouda; Katsuhiko Iwasaki; Ayako Shoji; Tadakazu Hisamatsu
Journal:  J Crohns Colitis       Date:  2020-08-26       Impact factor: 9.071

Review 10.  A Systematic Review of Factors Associated with Non-Adherence to Treatment for Immune-Mediated Inflammatory Diseases.

Authors:  Eleni Vangeli; Savita Bakhshi; Anna Baker; Abigail Fisher; Delaney Bucknor; Ulrich Mrowietz; Andrew J K Östör; Laurent Peyrin-Biroulet; Ana P Lacerda; John Weinman
Journal:  Adv Ther       Date:  2015-11-07       Impact factor: 3.845
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.